We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valereum Plc | AQSE:VLRM | Aquis Stock Exchange | Ordinary Share | GI000A2P2W41 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 4.65% | 5.625 | 5.50 | 6.50 | 6.00 | 5.61 | 5.625 | 200,980 | 15:29:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMVLRM
RNS Number : 8350U
Valereum PLC
28 November 2023
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR")
28/11/2023
Valereum Plc
("Valereum" or the "Company")
Removal of CLN's Update
Valereum Plc (AQUIS: VLRM), the Gibraltar technology group, is pleased to announce that the existing Convertible Loan Note under the previous terms of the funding facility announced on 31(st) January 2022 will be terminated with immediate effect. An agreement has been reached by both parties which will result in no more conversion notes being actioned.
James Formolli stated:
"This is fantastic news for the company and all its shareholders. Removing the current funding facility is the right thing to do; helping support our strategic ambitions for sustainable growth and shareholder value ahead of any further communications".
The directors of the Company accept responsibility for the contents of this announcement.
This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.
For more information, please visit the Company's website at Valereum.gi
Enquiries:
Valereum Plc
James Formolli, Chairman
Tel: +971 4584 6284
AQSE Corporate Adviser
First Sentinel Corporate Finance
Brian Stockbridge
Tel: +44 20 3855 5551
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXBVLBLXFLBFBE
(END) Dow Jones Newswires
November 28, 2023 05:00 ET (10:00 GMT)
1 Year Valereum Chart |
1 Month Valereum Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions